+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Rapid Microbiology Testing Market Size, Share & Trends Analysis Report By Method, By Application , By Product (Instruments , Reagents & Kits, and Consumables), By Regional Outlook and Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 407 Pages
  • April 2024
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5955296
The Global Rapid Microbiology Testing Market size is expected to reach $10.4 billion by 2031, rising at a market growth of 10.5% CAGR during the forecast period.

With foodborne illnesses posing a considerable public health concern globally, there has been a heightened emphasis on implementing stringent quality control measures throughout the food supply chain. This testing plays a pivotal role in this context by enabling food manufacturers to swiftly detect and mitigate microbial contamination, thereby ensuring food products' safety and integrity. Consequently, the food and beverage testing segment would acquire nearly, 40% of the total market share within the industrial testing segment by 2031.



The major strategies followed by the market participants are Product Launches as the key developmental strategy to keep pace with the changing demands of end users. For instance, in May, 2023, Neogen Corporation launched two new assays, Reveal for Histamine and Reveal Q+ for Histamine, designed for the detection of histamine in scombroid species of fish such as tuna and mahi-mahi. Key features of these assays include Easy-to-use Lateral Flow Tests, Water Extraction Method, Qualitative and Quantitative Options etc. Moreover, in January, 2021, Bruker Corporation announced the launch of MBT Sepsityper Kit US IVD, which is designed for the rapid identification of over 425 microorganisms from positive blood cultures. The MBT Sepsityper Kit US IVD leverages the MALDI Biotyper CA System, utilizing proteomic fingerprinting through high-throughput MALDI-TOF mass spectrometry. This technology allows for quick and accurate identification of a wide range of gram-negative and gram-positive bacteria, as well as yeasts like Candida auris.

Cardinal Matrix - Market Competition Analysis

Based on the Analysis presented in the Cardinal Matrix; Thermo Fisher Scientific, Inc., Abbott Laboratories and Danaher Corporation are the forerunners in the Market. In July, 2021, Abbott introduced Panbio COVID-19 Antigen Self-Test, for detection of SARS-CoV-2 virus in children and adults with symptoms or without any symptoms. This product launch aimed to fasten up testing of symptomatic and asymptomatic individuals and contacts of confirmed coronavirus cases. Abbott would provide numerous Panbio COVID-19 Rapid Antigen Tests accessible for self-use. Companies such as Becton, Dickinson and Company, BioMerieux S.A. and Bruker Corporation are some of the key innovators in Market.



COVID-19 Impact Analysis

The COVID-19 pandemic sparked a surge in demand for diagnostic testing, placing immense pressure on healthcare systems to rapidly identify and isolate infected individuals, trace contacts, and implement effective containment measures. Moreover, in response to the COVID-19 pandemic, governments, healthcare institutions, and industry stakeholders made significant investments in expanding testing infrastructure and scaling up production of testing technologies. Hence, the COVID-19 pandemic positively impacted the market.

Market Growth Factors

The escalating incidence of infectious diseases worldwide has spurred a significant demand for testing solutions. Additionally, rapidly identifying infectious agents through microbiology testing allows for implementing timely intervention strategies to contain and mitigate disease spread. Thus, these factors will pose lucrative growth prospects for the market.

Healthcare-associated infections (HAIs) present substantial hazards to patients, resulting in extended hospitalizations, escalated healthcare expenditures, and potential fatalities. Moreover, the growing healthcare sector worldwide is a significant driver of demand for this testing, with expanding applications across various domains of clinical practice, public health, and healthcare delivery. Therefore, these aspects can boost the growth of the market.

Market Restraining Factors

Navigating these regulatory pathways demands a profound understanding of the relevant regulations, documentation requirements, and procedural intricacies, which can be particularly daunting for smaller firms with limited resources and expertise. Additionally, for smaller companies operating in the market, the challenge of regulatory compliance is further exacerbated by resource constraints and financial limitations. Thus, these aspects can hamper the growth of the market.



The leading players in the market are competing with diverse innovative offerings to remain competitive in the market. The above illustration shows the percentage of revenue shared by some of the leading companies in the market. The leading players of the market are adopting various strategies in order to cater demand coming from the different industries. The key developmental strategies in the market are Product Launches and Product Expansions.

By Method Analysis

On the basis of method, the market is divided into growth-based rapid microbiology testing, cellular component-based rapid microbiology testing, nucleic acid-based rapid microbiology testing, viability-based rapid microbiology testing, and others. In 2023, the cellular component-based rapid microbiology testing segment witnessed a 25% revenue share in the market. Cellular component-based assays leverage advanced technologies, such as nucleic acid amplification techniques and immunoassays, to expedite assay kinetics and reduce turnaround times. Rapid amplification and detection of microbial nucleic acids or proteins within cellular specimens enable faster diagnosis of infectious diseases, facilitating prompt initiation of targeted therapy and infection control measures.

By Application Analysis

Based on application, the market is divided into clinical disease diagnosis, industrial testing, and research applications. The clinical disease diagnosis segment recorded a 22.5% revenue share in the market in 2023. The escalating burden of infectious diseases globally has fueled the demand for this testing in clinical diagnosis. In order to start the right therapy and avoid complications, diseases like lung infections, urinary tract infections, bloodstream infections, and gastrointestinal infections need to have the causing bacteria quickly identified.



By Product Analysis

Based on product, the market is segmented into instruments, reagents & kits, and consumables. In 2023, the reagents and kits segment acquired a 35% revenue share in the market. The growing adoption of molecular diagnostic techniques, such as polymerase chain reaction (PCR), nucleic acid amplification tests (NAATs), and next-generation sequencing (NGS), has fueled demand for reagents and kits used in nucleic acid-based assays. Hence, these factors can enhance the demand in the segment.

By Regional Analysis

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured a 38% revenue share in the market in 2023. North America boasts a well-developed healthcare infrastructure comprising state-of-the-art clinical laboratories, research institutions, and healthcare facilities with advanced diagnostic technologies. The region's sophisticated healthcare ecosystem provides a conducive environment for adopting and integrating testing solutions into routine clinical practice. Hence, these factors can assist in the expansion of the segment.

Market Competition and Attributes



The Market is highly competitive, driven by advancements in technology and the demand for quick and accurate testing solutions. Key players like bioMérieux, Thermo Fisher Scientific, and Merck KGaA vie for market share by innovating rapid diagnostic tools and expanding their global reach through strategic partnerships and acquisitions.

Recent Strategies Deployed in the Market

  • Apr-2024: QuidelOrtho Corp. received FDA 510(k) clearance for its QuickVue COVID-19 test, allowing its use in home and medical facility settings with CLIA certificates of waiver. This test is designed for symptomatic individuals within six days of symptom onset, approved for self-testing in individuals aged 14 or older and for administration by an adult in those aged two and older.
  • Aug-2023: Danaher Corporation signed an agreement to acquire Abcam plc, a protein research tools manufacturer. This acquisition aligned with Danaher's strategy in the Life Sciences sector, aiming to advance disease mapping and accelerate drug discovery processes.
  • May-2023: Neogen Corporation has launched two new assays for the detection of natural toxins: Reveal Q+ for DON EndPoint and Reveal Q+ for Aflatoxin EndPoint. These assays are quantitative lateral flow tests designed for accurate and rapid detection, particularly suitable for situations requiring increased workflow output. They are intended for use with Neogen's Raptor Solo Platform.
  • Aug-2022: Becton, Dickinson and Company and Accelerate Diagnostics, Inc., a Biotechnology company, entered a worldwide commercial collaboration agreement. BD would offer Accelerate's rapid testing solution for antibiotic resistance and susceptibility, complementing BD's Clinical Microbiology portfolio. This partnership aimed to help clinicians make faster treatment decisions, reduce healthcare costs, and address the global threat of antimicrobial resistance.
  • May-2022; BioMérieux acquired Specific Diagnostics, a U.S.-based company specializing in rapid antimicrobial susceptibility testing (AST) from positive blood cultures. This acquisition aimed to bolster bioMérieux's leadership in clinical microbiology and strengthen its fight against Antimicrobial Resistance (AMR).

List of Key Companies Profiled

  • BioMerieux S.A.
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Bruker Corporation
  • QuidelOrtho Corporation
  • Charles River Laboratories International, Inc.
  • Neogen Corporation

MarketReport Segmentation

By Method

  • Growth-based Rapid Microbiology Testing
  • Cellular Component-based Rapid Microbiology Testing
  • Nucleic Acid-based Rapid Microbiology Testing
  • Viability-based Rapid Microbiology Testing
  • Others

By Application

  • Industrial Testing
  • Food & Beverage Testing
  • Pharmaceutical & Biological Drug Testing
  • Environmental Testing
  • Cosmetics & Personal Care Products Testing
  • Others
  • Clinical Disease Diagnosis
  • Research Applications

By Product

  • Instruments
  • Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems
  • Mass Spectrometers
  • PCR Systems
  • Bioluminescence & Fluorescence-based Detection Systems
  • Cytometers
  • Active Air Samplers
  • Others
  • Reagents & Kits
  • Consumables

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Rapid Microbiology Testing Market, by Method
1.4.2 Global Rapid Microbiology Testing Market, by Application
1.4.3 Global Rapid Microbiology Testing Market, by Product
1.4.4 Global Rapid Microbiology Testing Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, Aug - 2023, May) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Global Rapid Microbiology Testing Market by Method
5.1 Global Growth-based Rapid Microbiology Testing Market by Region
5.2 Global Cellular Component-based Rapid Microbiology Testing Market by Region
5.3 Global Nucleic Acid-based Rapid Microbiology Testing Market by Region
5.4 Global Viability-based Rapid Microbiology Testing Market by Region
5.5 Global Others Market by Region
Chapter 6. Global Rapid Microbiology Testing Market by Application
6.1 Global Industrial Testing Market by Region
6.2 Global Rapid Microbiology Testing Market by Industrial Testing Type
6.2.1 Global Food & Beverage Testing Market by Region
6.2.2 Global Pharmaceutical & Biological Drug Testing Market by Region
6.2.3 Global Environmental Testing Market by Region
6.2.4 Global Cosmetics & Personal Care Products Testing Market by Region
6.2.5 Global Others Market by Region
6.3 Global Clinical Disease Diagnosis Market by Region
6.4 Global Research Applications Market by Region
Chapter 7. Global Rapid Microbiology Testing Market by Product
7.1 Global Instruments Market by Region
7.2 Global Rapid Microbiology Testing Market by Instruments Type
7.2.1 Global Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems Market by Region
7.2.2 Global Mass Spectrometers Market by Region
7.2.3 Global PCR Systems Market by Region
7.2.4 Global Bioluminescence & Fluorescence-based Detection Systems Market by Region
7.2.5 Global Cytometers Market by Region
7.2.6 Global Active Air Samplers Market by Region
7.2.7 Global Others Market by Region
7.3 Global Reagents & Kits Market by Region
7.4 Global Consumables Market by Region
Chapter 8. Global Rapid Microbiology Testing Market by Region
8.1 North America Rapid Microbiology Testing Market
8.1.1 North America Rapid Microbiology Testing Market by Method
8.1.1.1 North America Growth-based Rapid Microbiology Testing Market by Country
8.1.1.2 North America Cellular Component-based Rapid Microbiology Testing Market by Country
8.1.1.3 North America Nucleic Acid-based Rapid Microbiology Testing Market by Country
8.1.1.4 North America Viability-based Rapid Microbiology Testing Market by Country
8.1.1.5 North America Others Market by Country
8.1.2 North America Rapid Microbiology Testing Market by Application
8.1.2.1 North America Industrial Testing Market by Country
8.1.2.2 North America Rapid Microbiology Testing Market by Industrial Testing Type
8.1.2.2.1 North America Food & Beverage Testing Market by Country
8.1.2.2.2 North America Pharmaceutical & Biological Drug Testing Market by Country
8.1.2.2.3 North America Environmental Testing Market by Country
8.1.2.2.4 North America Cosmetics & Personal Care Products Testing Market by Country
8.1.2.2.5 North America Others Market by Country
8.1.2.3 North America Clinical Disease Diagnosis Market by Country
8.1.2.4 North America Research Applications Market by Country
8.1.3 North America Rapid Microbiology Testing Market by Product
8.1.3.1 North America Instruments Market by Country
8.1.3.2 North America Rapid Microbiology Testing Market by Instruments Type
8.1.3.2.1 North America Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems Market by Country
8.1.3.2.2 North America Mass Spectrometers Market by Country
8.1.3.2.3 North America PCR Systems Market by Country
8.1.3.2.4 North America Bioluminescence & Fluorescence-based Detection Systems Market by Country
8.1.3.2.5 North America Cytometers Market by Country
8.1.3.2.6 North America Active Air Samplers Market by Country
8.1.3.2.7 North America Others Market by Country
8.1.3.3 North America Reagents & Kits Market by Country
8.1.3.4 North America Consumables Market by Country
8.1.4 North America Rapid Microbiology Testing Market by Country
8.1.4.1 US Rapid Microbiology Testing Market
8.1.4.1.1 US Rapid Microbiology Testing Market by Method
8.1.4.1.2 US Rapid Microbiology Testing Market by Application
8.1.4.1.2.1 US Rapid Microbiology Testing Market by Industrial Testing Type
8.1.4.1.3 US Rapid Microbiology Testing Market by Product
8.1.4.1.3.1 US Rapid Microbiology Testing Market by Instruments Type
8.1.4.2 Canada Rapid Microbiology Testing Market
8.1.4.2.1 Canada Rapid Microbiology Testing Market by Method
8.1.4.2.2 Canada Rapid Microbiology Testing Market by Application
8.1.4.2.2.1 Canada Rapid Microbiology Testing Market by Industrial Testing Type
8.1.4.2.3 Canada Rapid Microbiology Testing Market by Product
8.1.4.2.3.1 Canada Rapid Microbiology Testing Market by Instruments Type
8.1.4.3 Mexico Rapid Microbiology Testing Market
8.1.4.3.1 Mexico Rapid Microbiology Testing Market by Method
8.1.4.3.2 Mexico Rapid Microbiology Testing Market by Application
8.1.4.3.2.1 Mexico Rapid Microbiology Testing Market by Industrial Testing Type
8.1.4.3.3 Mexico Rapid Microbiology Testing Market by Product
8.1.4.3.3.1 Mexico Rapid Microbiology Testing Market by Instruments Type
8.1.4.4 Rest of North America Rapid Microbiology Testing Market
8.1.4.4.1 Rest of North America Rapid Microbiology Testing Market by Method
8.1.4.4.2 Rest of North America Rapid Microbiology Testing Market by Application
8.1.4.4.2.1 Rest of North America Rapid Microbiology Testing Market by Industrial Testing Type
8.1.4.4.3 Rest of North America Rapid Microbiology Testing Market by Product
8.1.4.4.3.1 Rest of North America Rapid Microbiology Testing Market by Instruments Type
8.2 Europe Rapid Microbiology Testing Market
8.2.1 Europe Rapid Microbiology Testing Market by Method
8.2.1.1 Europe Growth-based Rapid Microbiology Testing Market by Country
8.2.1.2 Europe Cellular Component-based Rapid Microbiology Testing Market by Country
8.2.1.3 Europe Nucleic Acid-based Rapid Microbiology Testing Market by Country
8.2.1.4 Europe Viability-based Rapid Microbiology Testing Market by Country
8.2.1.5 Europe Others Market by Country
8.2.2 Europe Rapid Microbiology Testing Market by Application
8.2.2.1 Europe Industrial Testing Market by Country
8.2.2.2 Europe Rapid Microbiology Testing Market by Industrial Testing Type
8.2.2.2.1 Europe Food & Beverage Testing Market by Country
8.2.2.2.2 Europe Pharmaceutical & Biological Drug Testing Market by Country
8.2.2.2.3 Europe Environmental Testing Market by Country
8.2.2.2.4 Europe Cosmetics & Personal Care Products Testing Market by Country
8.2.2.2.5 Europe Others Market by Country
8.2.2.3 Europe Clinical Disease Diagnosis Market by Country
8.2.2.4 Europe Research Applications Market by Country
8.2.3 Europe Rapid Microbiology Testing Market by Product
8.2.3.1 Europe Instruments Market by Country
8.2.3.2 Europe Rapid Microbiology Testing Market by Instruments Type
8.2.3.2.1 Europe Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems Market by Country
8.2.3.2.2 Europe Mass Spectrometers Market by Country
8.2.3.2.3 Europe PCR Systems Market by Country
8.2.3.2.4 Europe Bioluminescence & Fluorescence-based Detection Systems Market by Country
8.2.3.2.5 Europe Cytometers Market by Country
8.2.3.2.6 Europe Active Air Samplers Market by Country
8.2.3.2.7 Europe Others Market by Country
8.2.3.3 Europe Reagents & Kits Market by Country
8.2.3.4 Europe Consumables Market by Country
8.2.4 Europe Rapid Microbiology Testing Market by Country
8.2.4.1 Germany Rapid Microbiology Testing Market
8.2.4.1.1 Germany Rapid Microbiology Testing Market by Method
8.2.4.1.2 Germany Rapid Microbiology Testing Market by Application
8.2.4.1.2.1 Germany Rapid Microbiology Testing Market by Industrial Testing Type
8.2.4.1.3 Germany Rapid Microbiology Testing Market by Product
8.2.4.1.3.1 Germany Rapid Microbiology Testing Market by Instruments Type
8.2.4.2 UK Rapid Microbiology Testing Market
8.2.4.2.1 UK Rapid Microbiology Testing Market by Method
8.2.4.2.2 UK Rapid Microbiology Testing Market by Application
8.2.4.2.2.1 UK Rapid Microbiology Testing Market by Industrial Testing Type
8.2.4.2.3 UK Rapid Microbiology Testing Market by Product
8.2.4.2.3.1 UK Rapid Microbiology Testing Market by Instruments Type
8.2.4.3 France Rapid Microbiology Testing Market
8.2.4.3.1 France Rapid Microbiology Testing Market by Method
8.2.4.3.2 France Rapid Microbiology Testing Market by Application
8.2.4.3.2.1 France Rapid Microbiology Testing Market by Industrial Testing Type
8.2.4.3.3 France Rapid Microbiology Testing Market by Product
8.2.4.3.3.1 France Rapid Microbiology Testing Market by Instruments Type
8.2.4.4 Russia Rapid Microbiology Testing Market
8.2.4.4.1 Russia Rapid Microbiology Testing Market by Method
8.2.4.4.2 Russia Rapid Microbiology Testing Market by Application
8.2.4.4.2.1 Russia Rapid Microbiology Testing Market by Industrial Testing Type
8.2.4.4.3 Russia Rapid Microbiology Testing Market by Product
8.2.4.4.3.1 Russia Rapid Microbiology Testing Market by Instruments Type
8.2.4.5 Spain Rapid Microbiology Testing Market
8.2.4.5.1 Spain Rapid Microbiology Testing Market by Method
8.2.4.5.2 Spain Rapid Microbiology Testing Market by Application
8.2.4.5.2.1 Spain Rapid Microbiology Testing Market by Industrial Testing Type
8.2.4.5.3 Spain Rapid Microbiology Testing Market by Product
8.2.4.5.3.1 Spain Rapid Microbiology Testing Market by Instruments Type
8.2.4.6 Italy Rapid Microbiology Testing Market
8.2.4.6.1 Italy Rapid Microbiology Testing Market by Method
8.2.4.6.2 Italy Rapid Microbiology Testing Market by Application
8.2.4.6.2.1 Italy Rapid Microbiology Testing Market by Industrial Testing Type
8.2.4.6.3 Italy Rapid Microbiology Testing Market by Product
8.2.4.6.3.1 Italy Rapid Microbiology Testing Market by Instruments Type
8.2.4.7 Rest of Europe Rapid Microbiology Testing Market
8.2.4.7.1 Rest of Europe Rapid Microbiology Testing Market by Method
8.2.4.7.2 Rest of Europe Rapid Microbiology Testing Market by Application
8.2.4.7.2.1 Rest of Europe Rapid Microbiology Testing Market by Industrial Testing Type
8.2.4.7.3 Rest of Europe Rapid Microbiology Testing Market by Product
8.2.4.7.3.1 Rest of Europe Rapid Microbiology Testing Market by Instruments Type
8.3 Asia Pacific Rapid Microbiology Testing Market
8.3.1 Asia Pacific Rapid Microbiology Testing Market by Method
8.3.1.1 Asia Pacific Growth-based Rapid Microbiology Testing Market by Country
8.3.1.2 Asia Pacific Cellular Component-based Rapid Microbiology Testing Market by Country
8.3.1.3 Asia Pacific Nucleic Acid-based Rapid Microbiology Testing Market by Country
8.3.1.4 Asia Pacific Viability-based Rapid Microbiology Testing Market by Country
8.3.1.5 Asia Pacific Others Market by Country
8.3.2 Asia Pacific Rapid Microbiology Testing Market by Application
8.3.2.1 Asia Pacific Industrial Testing Market by Country
8.3.2.2 Asia Pacific Rapid Microbiology Testing Market by Industrial Testing Type
8.3.2.2.1 Asia Pacific Food & Beverage Testing Market by Country
8.3.2.2.2 Asia Pacific Pharmaceutical & Biological Drug Testing Market by Country
8.3.2.2.3 Asia Pacific Environmental Testing Market by Country
8.3.2.2.4 Asia Pacific Cosmetics & Personal Care Products Testing Market by Country
8.3.2.2.5 Asia Pacific Others Market by Country
8.3.2.3 Asia Pacific Clinical Disease Diagnosis Market by Country
8.3.2.4 Asia Pacific Research Applications Market by Country
8.3.3 Asia Pacific Rapid Microbiology Testing Market by Product
8.3.3.1 Asia Pacific Instruments Market by Country
8.3.3.2 Asia Pacific Rapid Microbiology Testing Market by Instruments Type
8.3.3.2.1 Asia Pacific Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems Market by Country
8.3.3.2.2 Asia Pacific Mass Spectrometers Market by Country
8.3.3.2.3 Asia Pacific PCR Systems Market by Country
8.3.3.2.4 Asia Pacific Bioluminescence & Fluorescence-based Detection Systems Market by Country
8.3.3.2.5 Asia Pacific Cytometers Market by Country
8.3.3.2.6 Asia Pacific Active Air Samplers Market by Country
8.3.3.2.7 Asia Pacific Others Market by Country
8.3.3.3 Asia Pacific Reagents & Kits Market by Country
8.3.3.4 Asia Pacific Consumables Market by Country
8.3.4 Asia Pacific Rapid Microbiology Testing Market by Country
8.3.4.1 China Rapid Microbiology Testing Market
8.3.4.1.1 China Rapid Microbiology Testing Market by Method
8.3.4.1.2 China Rapid Microbiology Testing Market by Application
8.3.4.1.2.1 China Rapid Microbiology Testing Market by Industrial Testing Type
8.3.4.1.3 China Rapid Microbiology Testing Market by Product
8.3.4.1.3.1 China Rapid Microbiology Testing Market by Instruments Type
8.3.4.2 Japan Rapid Microbiology Testing Market
8.3.4.2.1 Japan Rapid Microbiology Testing Market by Method
8.3.4.2.2 Japan Rapid Microbiology Testing Market by Application
8.3.4.2.2.1 Japan Rapid Microbiology Testing Market by Industrial Testing Type
8.3.4.2.3 Japan Rapid Microbiology Testing Market by Product
8.3.4.2.3.1 Japan Rapid Microbiology Testing Market by Instruments Type
8.3.4.3 India Rapid Microbiology Testing Market
8.3.4.3.1 India Rapid Microbiology Testing Market by Method
8.3.4.3.2 India Rapid Microbiology Testing Market by Application
8.3.4.3.2.1 India Rapid Microbiology Testing Market by Industrial Testing Type
8.3.4.3.3 India Rapid Microbiology Testing Market by Product
8.3.4.3.3.1 India Rapid Microbiology Testing Market by Instruments Type
8.3.4.4 South Korea Rapid Microbiology Testing Market
8.3.4.4.1 South Korea Rapid Microbiology Testing Market by Method
8.3.4.4.2 South Korea Rapid Microbiology Testing Market by Application
8.3.4.4.2.1 South Korea Rapid Microbiology Testing Market by Industrial Testing Type
8.3.4.4.3 South Korea Rapid Microbiology Testing Market by Product
8.3.4.4.3.1 South Korea Rapid Microbiology Testing Market by Instruments Type
8.3.4.5 Australia Rapid Microbiology Testing Market
8.3.4.5.1 Australia Rapid Microbiology Testing Market by Method
8.3.4.5.2 Australia Rapid Microbiology Testing Market by Application
8.3.4.5.2.1 Australia Rapid Microbiology Testing Market by Industrial Testing Type
8.3.4.5.3 Australia Rapid Microbiology Testing Market by Product
8.3.4.5.3.1 Australia Rapid Microbiology Testing Market by Instruments Type
8.3.4.6 Malaysia Rapid Microbiology Testing Market
8.3.4.6.1 Malaysia Rapid Microbiology Testing Market by Method
8.3.4.6.2 Malaysia Rapid Microbiology Testing Market by Application
8.3.4.6.2.1 Malaysia Rapid Microbiology Testing Market by Industrial Testing Type
8.3.4.6.3 Malaysia Rapid Microbiology Testing Market by Product
8.3.4.6.3.1 Malaysia Rapid Microbiology Testing Market by Instruments Type
8.3.4.7 Rest of Asia Pacific Rapid Microbiology Testing Market
8.3.4.7.1 Rest of Asia Pacific Rapid Microbiology Testing Market by Method
8.3.4.7.2 Rest of Asia Pacific Rapid Microbiology Testing Market by Application
8.3.4.7.2.1 Rest of Asia Pacific Rapid Microbiology Testing Market by Industrial Testing Type
8.3.4.7.3 Rest of Asia Pacific Rapid Microbiology Testing Market by Product
8.3.4.7.3.1 Rest of Asia Pacific Rapid Microbiology Testing Market by Instruments Type
8.4 LAMEA Rapid Microbiology Testing Market
8.4.1 LAMEA Rapid Microbiology Testing Market by Method
8.4.1.1 LAMEA Growth-based Rapid Microbiology Testing Market by Country
8.4.1.2 LAMEA Cellular Component-based Rapid Microbiology Testing Market by Country
8.4.1.3 LAMEA Nucleic Acid-based Rapid Microbiology Testing Market by Country
8.4.1.4 LAMEA Viability-based Rapid Microbiology Testing Market by Country
8.4.1.5 LAMEA Others Market by Country
8.4.2 LAMEA Rapid Microbiology Testing Market by Application
8.4.2.1 LAMEA Industrial Testing Market by Country
8.4.2.2 LAMEA Rapid Microbiology Testing Market by Industrial Testing Type
8.4.2.2.1 LAMEA Food & Beverage Testing Market by Country
8.4.2.2.2 LAMEA Pharmaceutical & Biological Drug Testing Market by Country
8.4.2.2.3 LAMEA Environmental Testing Market by Country
8.4.2.2.4 LAMEA Cosmetics & Personal Care Products Testing Market by Country
8.4.2.2.5 LAMEA Others Market by Country
8.4.2.3 LAMEA Clinical Disease Diagnosis Market by Country
8.4.2.4 LAMEA Research Applications Market by Country
8.4.3 LAMEA Rapid Microbiology Testing Market by Product
8.4.3.1 LAMEA Instruments Market by Country
8.4.3.2 LAMEA Rapid Microbiology Testing Market by Instruments Type
8.4.3.2.1 LAMEA Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems Market by Country
8.4.3.2.2 LAMEA Mass Spectrometers Market by Country
8.4.3.2.3 LAMEA PCR Systems Market by Country
8.4.3.2.4 LAMEA Bioluminescence & Fluorescence-based Detection Systems Market by Country
8.4.3.2.5 LAMEA Cytometers Market by Country
8.4.3.2.6 LAMEA Active Air Samplers Market by Country
8.4.3.2.7 LAMEA Others Market by Country
8.4.3.3 LAMEA Reagents & Kits Market by Country
8.4.3.4 LAMEA Consumables Market by Country
8.4.4 LAMEA Rapid Microbiology Testing Market by Country
8.4.4.1 Brazil Rapid Microbiology Testing Market
8.4.4.1.1 Brazil Rapid Microbiology Testing Market by Method
8.4.4.1.2 Brazil Rapid Microbiology Testing Market by Application
8.4.4.1.2.1 Brazil Rapid Microbiology Testing Market by Industrial Testing Type
8.4.4.1.3 Brazil Rapid Microbiology Testing Market by Product
8.4.4.1.3.1 Brazil Rapid Microbiology Testing Market by Instruments Type
8.4.4.2 Argentina Rapid Microbiology Testing Market
8.4.4.2.1 Argentina Rapid Microbiology Testing Market by Method
8.4.4.2.2 Argentina Rapid Microbiology Testing Market by Application
8.4.4.2.2.1 Argentina Rapid Microbiology Testing Market by Industrial Testing Type
8.4.4.2.3 Argentina Rapid Microbiology Testing Market by Product
8.4.4.2.3.1 Argentina Rapid Microbiology Testing Market by Instruments Type
8.4.4.3 UAE Rapid Microbiology Testing Market
8.4.4.3.1 UAE Rapid Microbiology Testing Market by Method
8.4.4.3.2 UAE Rapid Microbiology Testing Market by Application
8.4.4.3.2.1 UAE Rapid Microbiology Testing Market by Industrial Testing Type
8.4.4.3.3 UAE Rapid Microbiology Testing Market by Product
8.4.4.3.3.1 UAE Rapid Microbiology Testing Market by Instruments Type
8.4.4.4 Saudi Arabia Rapid Microbiology Testing Market
8.4.4.4.1 Saudi Arabia Rapid Microbiology Testing Market by Method
8.4.4.4.2 Saudi Arabia Rapid Microbiology Testing Market by Application
8.4.4.4.2.1 Saudi Arabia Rapid Microbiology Testing Market by Industrial Testing Type
8.4.4.4.3 Saudi Arabia Rapid Microbiology Testing Market by Product
8.4.4.4.3.1 Saudi Arabia Rapid Microbiology Testing Market by Instruments Type
8.4.4.5 South Africa Rapid Microbiology Testing Market
8.4.4.5.1 South Africa Rapid Microbiology Testing Market by Method
8.4.4.5.2 South Africa Rapid Microbiology Testing Market by Application
8.4.4.5.2.1 South Africa Rapid Microbiology Testing Market by Industrial Testing Type
8.4.4.5.3 South Africa Rapid Microbiology Testing Market by Product
8.4.4.5.3.1 South Africa Rapid Microbiology Testing Market by Instruments Type
8.4.4.6 Nigeria Rapid Microbiology Testing Market
8.4.4.6.1 Nigeria Rapid Microbiology Testing Market by Method
8.4.4.6.2 Nigeria Rapid Microbiology Testing Market by Application
8.4.4.6.2.1 Nigeria Rapid Microbiology Testing Market by Industrial Testing Type
8.4.4.6.3 Nigeria Rapid Microbiology Testing Market by Product
8.4.4.6.3.1 Nigeria Rapid Microbiology Testing Market by Instruments Type
8.4.4.7 Rest of LAMEA Rapid Microbiology Testing Market
8.4.4.7.1 Rest of LAMEA Rapid Microbiology Testing Market by Method
8.4.4.7.2 Rest of LAMEA Rapid Microbiology Testing Market by Application
8.4.4.7.2.1 Rest of LAMEA Rapid Microbiology Testing Market by Industrial Testing Type
8.4.4.7.3 Rest of LAMEA Rapid Microbiology Testing Market by Product
8.4.4.7.3.1 Rest of LAMEA Rapid Microbiology Testing Market by Instruments Type
Chapter 9. Company Profiles
9.1 BioMerieux S.A.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 QuidelOrtho Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Trials and Approvals:
9.3 Merck KGaA
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 Neogen Corporation
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.4.6 SWOT Analysis
9.5 Danaher Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.6 SWOT Analysis
9.6 Abbott Laboratories
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product launches and Product expansions:
9.6.6 SWOT Analysis
9.7 Thermo Fisher Scientific, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.7.6 SWOT Analysis
9.8 Bruker Corporation
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Product Launches and Product Expansions:
9.8.6 SWOT Analysis
9.9 Charles River Laboratories International, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 SWOT Analysis
9.10. Becton, Dickinson, and Company
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.6 SWOT Analysis
Chapter 10. Winning Imperatives for Rapid Microbiology Testing Market

Companies Mentioned

  • BioMerieux S.A.
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Bruker Corporation
  • QuidelOrtho Corporation
  • Charles River Laboratories International, Inc.
  • Neogen Corporation

Methodology

Loading
LOADING...